ORG 20091

Drug Profile

ORG 20091

Latest Information Update: 08 Jan 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Organon
  • Class Anxiolytics; Nootropics; Pyridines; Small molecules; Thiazoles
  • Mechanism of Action Alpha 2 adrenergic receptor antagonists; Muscarinic M1 receptor agonists; Serotonin 1A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Cognition disorders; Major depressive disorder

Most Recent Events

  • 08 Jan 2001 Discontinued-Preclinical for Anxiety disorders in Netherlands (Unknown route)
  • 08 Jan 2001 Discontinued-Preclinical for Cognition disorders in Netherlands (Unknown route)
  • 08 Jan 2001 Discontinued-Preclinical for Depression in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top